Comparative Analysis of Antioxidant, Anticholinesterase, and Antibacterial Activity of Microbial Chondroitin Sulfate and Commercial Chondroitin Sulfate
Chemistry & Biodiversity · 2023-10 · 20 (10)
DOI: 10.1002/cbdv.202300924 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Chemistry & Biodiversity, online erschienen am 08.09.2023. Verfasst von Tuba Unver und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Inonu University, Malatya, Turkey. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Antioxidants, Cholinesterase Inhibitors, Chondroitin Sulfates. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 47 Literaturangaben.
Abstract (Originalsprache)
Chondroitin synthesis was performed using the recombinant Escherichia coli (C2987) strain created by transforming the plasmid pETM6‐PACF‐ vgb , which carries the genes responsible for chondroitin synthesis, kfoA , kfoC , kfoF , and the Vitreoscilla hemoglobin gene ( vgb ). Then, Microbial chondroitin sulfate (MCS)’s antioxidant, anticholinesterase, and antibacterial activity were compared with commercial chondroitin sulfate (CCS). The antioxidant studies revealed that the MCS and CCS samples could be potential targets for scavenging radicals and cupric ion reduction. MCS demonstrated better antioxidant properties in the ABTS assay with the IC50 value of 0.66 mg than CCS. MCS showed 2.5‐fold for DPPH and almost 5‐fold for ABTS⋅+ (with a value of 3.85 mg/mL) better activity than the CCS. However, the compounds were not active for cholinesterase enzyme inhibitions. In the antibacterial assay, the Minimum inhibitory concentration (MIC) values of MCS against S. aureus , E. aerogenes , E. coli , P. aeruginosa , and K. pneumoniae (0.12, 0.18, 0.12, 0.18, and 0.18 g/mL, respectively) were found to be greater than that of CCS (0.42, 0.48, 0.36, 0.36, and 0.36 g/mL, respectively). This study demonstrates that MCS is a potent pharmacological agent due to its physicochemical properties, and its usability as a therapeutic‐preventive agent will shed light on future studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Inonu University, Malatya, Turkey.
- Department of Medical Biology, Faculty of Medicine, Turgut Ozal University, Malatya, Turkey.
- Department of Pharmaceutical Fundamental Sciences, Faculty of Pharmacy, Dicle University, Diyarbakır, Turkey.
- Department of Analytical Chemistry, Faculty of Pharmacy, Dicle University, Diyarbakır, Turkey.
ORCID-Profile: Tuba Unver, Ayse Sebnem Erenler, Murat Bingul, Mehmet Boga
Zitieren
APA
Unver, T., Erenler, A. S., Bingul, M., & Boga, M. (2023). Comparative Analysis of Antioxidant, Anticholinesterase, and Antibacterial Activity of Microbial Chondroitin Sulfate and Commercial Chondroitin Sulfate. Chemistry & Biodiversity, 20(10). https://doi.org/10.1002/cbdv.202300924
Vancouver
Unver T, Erenler AS, Bingul M, Boga M. Comparative Analysis of Antioxidant, Anticholinesterase, and Antibacterial Activity of Microbial Chondroitin Sulfate and Commercial Chondroitin Sulfate. Chemistry & Biodiversity. 2023;20(10). doi:10.1002/cbdv.202300924
BibTeX
@article{Unver2023,
author = {Unver, Tuba and Erenler, Ayse Sebnem and Bingul, Murat and Boga, Mehmet},
title = {Comparative Analysis of Antioxidant, Anticholinesterase, and Antibacterial Activity of Microbial Chondroitin Sulfate and Commercial Chondroitin Sulfate},
journal = {Chemistry & Biodiversity},
year = {2023},
volume = {20},
number = {10},
doi = {10.1002/cbdv.202300924}
}
EUVIMED